Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ITI Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited10.759714194522.6445
Domestic EquitiesDivi's Laboratories Limited8.96233117118.8616
Domestic EquitiesApollo Hospitals Enterprise Limited6.21251878413.0746
Domestic EquitiesMax Healthcare Institute Limited5.488412072111.5506
Domestic EquitiesTorrent Pharmaceuticals Limited4.97722644610.4747
Domestic EquitiesAurobindo Pharma Limited4.5520793249.5800
Domestic EquitiesLupin Limited3.6876360507.7608
Domestic EquitiesFortis Healthcare Limited3.6626905247.7081
Domestic EquitiesAlkem Laboratories Limited3.3595124537.0702
Domestic EquitiesAster DM Healthcare Limited2.81081071345.9154
Domestic EquitiesCohance Lifesciences Limited2.65011462715.5773
Domestic EquitiesNeuland Laboratories Limited2.645742025.5681
Domestic EquitiesWockhardt Limited2.5506388355.3678
Domestic EquitiesAbbott India Limited2.475518905.2098
Domestic EquitiesGlenmark Pharmaceuticals Limited2.0399212964.2931
Domestic EquitiesMankind Pharma Limited1.9710195294.1480
Domestic EquitiesLaurus Labs Limited1.8969413693.9921
Domestic EquitiesDr. Reddy's Laboratories Limited1.8252315343.8412
Domestic EquitiesCipla Limited1.8114287923.8121
Domestic EquitiesIPCA Laboratories Limited1.5716224883.3075
Domestic EquitiesSai Life Sciences Limited1.5713395953.3068
Domestic EquitiesSBI Life Insurance Company Limited1.4083148302.9638
Domestic EquitiesFDC Limited1.3674761792.8777
Domestic EquitiesHealthcare Global Enterprises Limited1.3302472852.7995
Domestic EquitiesBiocon Limited1.3195757062.7769
Domestic EquitiesSumitomo Chemical India Limited1.3118673942.7608
Domestic EquitiesPark Medi World Limited1.30691790322.7505
Domestic EquitiesLinde India Limited1.225942952.5800
Domestic EquitiesOrchid Pharma Limited1.2044362582.5348
Domestic EquitiesPiramal Pharma Limited1.19811630122.5215
Domestic EquitiesRainbow Childrens Medicare Limited1.0897201502.2933
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited1.051392132.2126
Domestic EquitiesOnesource Specialty Pharma Limited0.9342164591.9660
Domestic EquitiesStandard Engineering Technology Ltd0.89681633571.8873
Domestic EquitiesCaplin Point Laboratories Limited0.8807104491.8535
Domestic EquitiesPoly Medicure Limited0.8704120441.8318
Domestic EquitiesSupriya Lifescience Limited0.8149253701.7151
Domestic EquitiesAstraZeneca Pharma India Limited0.763818801.6074
Domestic EquitiesZydus Lifesciences Limited0.7064167921.4866
Domestic EquitiesShilpa Medicare Limited0.6806495681.4323
Domestic EquitiesSyngene International Limited0.3860171590.8124
Total 98.2288 206.7281
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)1.7712 3.7276
Total 1.7712 3.7276
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.